The susceptibilities of T-mycoplasmas (Ureaplasma urealyticum) to minocycline, demeclocycline, doxycycine, tetracycline, and erythromycin were determined by a direct tube dilution test. T-mycoplasma-positive urine sediments of 105 patients with a history of reproductive failure were used as inocula. Minocycline was found to be the most active of the group of antibiotics commonly used to eradicate T-mycoplasma infection. Based on the median initial minimum inhibitory concentration, minocycine was the lowest with 0.03 ,ug/ml, followed by demeclocycline and doxycycine with 0.125 ,ug/ml, tetracycline with 0.25 ,ug/ ml, and erythromycin with 2.0 p,g/ml. Six T-mycoplasma isolates which had been cloned three times were also tested for susceptibility to the same five antibiotics. The same susceptibility pattern was found. Strains resistant to high concentrations ofall antibiotics occurred. Strong positive correlation was seen in 21 patients between in vitro highly resistant strains and positive posttreatment cultures. These results indicate that empirical treatment of genital mycoplasma infections is not justified. Cultures should be taken pretreatment, susceptibility testing performed prior to treatment, and follow-up cultures done posttreatment.
T-mycoplasmas have been implicated in nongonococcal urethritis by Shepard (26, 27) and Bennett et al. (4) and in human reproductive failure by Kundsin et al. (20, 21) , Gnarpe and Friberg (14) , and Home et al. (17) . Furthermore, Home et al. (16) have described an endometrial lesion associated with the isolation of T strain mycoplasmas which may explain patient infertility. Determination ofthe antibiotic susceptibility of T-mycoplasmas recovered from patients who were treatment failures suggested that a possible cause for this failure was the existence of strains highly resistant to tetracycline, tetracycline analogues, and erythromycin. These antibiotics, as currently prescribed for T-mycoplasma infections, are shown in Table 1. In the present study, a direct drug susceptibility test was performed based on a similar method described for mycobacteria (2) . Urine sediment containing T-mycoplasmas was used as the inoculum instead of cloned T-mycoplasmas for two reasons. First, subculturing is frequently impossible. Hayflick (15) found that almost 70% of mycoplasmas isolated from human clinical materials could not be subcultured after initial isolation. Endogenous nutrients carried over from growth in the natural environment undoubtedly accounted for the initial isolation of this group of very fastidious mycoplasmas. Secondly, the composition of the growth medium has been shown to significantly influence certain properties. Because of their propensity to bind components from the medium, great caution must be exercised in describing characteristics of mycoplasma species. Their physical properties, antigenicity, antibiotic susceptibility, and even their reaction in certain diagnostic tests, have all been demonstrated to be related to the growth medium (6, 24) . A number of studies have indicated that the mycoplasma cell membrane influences antibiotic susceptibility. For example, resistance to tetracycline has been shown to involve a reduced permeability of the membrane to the antibiotic, rather than an alteration in a ribosomal protein synthesis, in several mycoplasmas (9, 25) .
MATERIALS AND METHODS
One hundred and five urine sediments from 105 patients found to be positive for T-mycoplasmas in the Surgical Bacteriology Laboratory, Peter Bent Brigham Hospital, Boston, Mass., were used in this study. These patients had a history of reproductive failure. Their specimens (urine and vaginal, and (27) cervical or urethral swab) were sent to the laboratory by private gynecologists and infertility clinics. The study was conducted over a 1-year period between August 1974 and August 1975. The T strains were identified by the simultaneous use of liquid and solid media as described by Kundsin (19) . Preparation of the antibiotic solutions. Standard minocycline, demeclocycline, and tetracycline powders of known potency were provided by the Lederle Laboratories (Pearl River, N.Y.). Erythromycin was purchased through the hospital pharmacy as sterile erythromycin gluceptate powder (Ilotycin, Dista Products Co., Eli Lilly and Co., Indianapolis, Ind.). Doxycycline was donated by the Pfizer Laboratories Division of Chas. Pfizer & Co., Inc. (New York, N.Y.). Minocycline hydrochloride had an activity of 876 ,ug/ml. The product was used without drying, because the potency factor corrects for moisture content, hydrochloride, and inactive materials. Demeclocycline hydrochloride and tetracycline hydrochloride were 100% active and needed no corrections.
The initial solutions (stock solutions) of minocycline, demeclocycline, and tetracycline were made up in 0.01 N hydrochloric acid, giving an antibiotic concentration of 1,000 ,g/ml. These stock solutions were each sterilized by passage through a membrane filter (0.22-,um pore size, Millipore Corp., Bedford, Mass. antibiotic per ml were made up on the day each antibiotic was tested. To each tube 0.025 ml of thawed, well-mixed urine sediment containing Tmycoplasmas was added, using a calibrated microtiter pipette. The tubes were closed with tight-fitting plastic caps. For each isolate a control tube containing 1 ml of Ford medium and 0.025 ml of urine sediment with T-mycoplasmas was inoculated simultaneously. All tubes were incubated at 36 C for 10 days and observed daily for color change.
Of 105 specimens from different patients, 102 Tmycoplasma isolates were tested for susceptibility to minocycline, 97 to demeclocycline, 58 to doxycycline, 18 to tetracycline, and 35 to erythromycin.
The MIC was defined as the lowest concentration of antibiotic inhibiting color change in broth by the T-mycoplasma isolate tested. The initial MIC was determined as the lowest concentration of antibiotic inhibiting color change caused by a given T-mycoplasma at the time the control tube containing the same strain changed. The lowest concentration of antibiotic that completely inhibited color change after 6 days of incubation was also noted and will be referred to as the "final MIC." It is included because color changes were slower to develop in the presence of antibiotic than in the controls without antibiotic. Therefore incubation must be prolonged until no further color changes occur. Incubation beyond 6 days did not result in any further color change. The final MIC represents only an upper limit of the true MIC at 6 days because of possible deterioration of the antibiotic.
To establish that the presence of 0.01 N hydrochloric acid used as solvent for minocycline, demeclocycline, and tetracycline had no effect on the growth of T-mycoplasmas, several experiments were performed similar to the tube dilution method, using a stock solution of 0.01 N hydrochcloric acid without antibiotic.
The T-mycoplasmas were not isolated from their original environment (urine) prior to testing. Table  2 shows the relative occurrence of other bacteria present in the 105 urine specimens used in this study.
To establish that cloned strains showed the same antibiotic susceptibilities, 6 isolates of T-myco- from M. C. Shepard); NUN was from the urine of an asymptomatic nun; BROWN was from a symptomatic patient with genitoinfectious disease; BAR-BARA was from the cervix of a patient with carcinoma in situ; and BOSTON T was from the fetal membranes of a middle trimester spontaneous abortion.
Titration of the urine specimens. The titer of each specimen was determined by adding 0.2 ml of urine sediment to 1.8 ml of Ford medium (7). This was carefully mixed (Vortex-Genie) to break up clumps and serial 10-fold dilutions were made in the same medium using 0.2 ml to 1.8 ml, contained in clear plastic screw-cap tubes, up to . The tubes were incubated at 36 C for seven days. The highest dilution in which a color change occurred was considered the end point. The results were read visually and expressed as titers of color-changing units (CCU). One hundred and twenty-five isolates of Tmycoplasmas in urine sediments were titrated.
Correlation between susceptibility test results and posttreatment urine cultures. Fifty of the 105 patients were recultured for the presence of T-mycoplasmas within a period of 4 to 8 weeks after completion of their antibiotic therapy. The posttreatment urine culture results were correlated with the final MIC of the prescribed antibiotic for each patient. Of these 50 patients, 2 were treated with minocycline, 25 with demeclocycline, 18 with doxycycline, and 4 with tetracycline. None was treated with erythromycin.
RESULTS
Of the 125 T-mycoplasma isolates titrated, 20 specimens with a titer of 10' CCU were not included in this study because they gave inconsistent results due to the low numbers of CCU. The distribution of the end points of the 105 remaining specimens is presented in Table 3 . Most specimens had a titer of 103 CCU or greater. Regardless of the titer of organisms in the urine sediments, the controls containing T strains without antibiotic showed color change within 48 h for all specimens. At a titer of 102 CCU, 20% of the controls changed within 24 h; at a titer 103 CCU, 75% of the controls changed within 24 h; at a titer of 104 CCU, 81% changed within 24 h; and at a titer of 105 CCU or greater, all controls changed within 24 h. Figures 1 and 2 summarize the initial MIC and the final MIC of four tetracycline components and erythromycin against T-mycoplasmas present in urine sediments. The results show that minocycline was clearly the most active compound at the lowest concentrations, followed by demeclocycline, doxycycline, and tetracycline. Erythromycin was considerably less active than the tetracyclines with a clustering of values in the 4.0-to 200-,ug/ml range (final MIC).
At an initial MIC of 0.03 ,ug/ml, 50% of the Tmycoplasmas were inhibited by minocycline, whereas only 25.8% were inhibited by demeclocycine, 13.8% by doxycycline, 11.1% by tetracycline, and 2.6% by erythromycin. At the final MIC, 2% of the T-mycoplasmas were still inhibited by 0.03 jig of minocycline per ml, whereas all the other antibiotics did not retain 4 ,ug/ ml). However, only 11.4% of the T-mycoplasmas were inhibited by 4 pug of erythromycin per ml. Table 5 outlines the in vitro susceptibility results of six cloned T-mycoplasma strains tested to the same five antibiotics. The titer of each inoculum is presented in the same table. The results were consistent with those obtained from the urine sediments. The same susceptibility pattern was followed. Minocycline again was the most active antibiotic, followed by doxycline, demeclocycline, tetracycline, and erythromycin. One strain (NUN) showed a lower final MIC for doxycycline. The BOSTON T strain was assayed twice, using inocula with different titers (once with 103 CCU, once with 104 CCU). Both tests gave the same MIC values. The BOSTON T strain was the most susceptible strain, and 960 was the least susceptible. As was observed for the clinical isolates, the susceptibility appeared to vary with the isolate tested.
The presence of 0.01 N hydrochloric acid, used as a solvent for some of the antibiotics, appeared to have no effect on the susceptibility test. The color change occurred in all the tubes containing 0.01 N HCl in broth (similarly diluted as in the actual test) and T strains at the same time a color change was observed in the control tubes containing broth and T strains. Table 6 outlines the data obtained by correlating the posttreatment urine culture results of 50 patients with the final MIC of the antibiotic used for treatment of their T-mycoplasma infection. Of these 50 patients, 29 had a negative urine specimen posttreatment and 21 had a positive urine specimen posttreatment. It was found that patients who carried T-mycoplasmas in the urine, requiring a final MIC of 4.0 ,ug or more of a tetracycline per ml in vitro, were still positive posttreatment. A final MIC of 1.0 ,ug/ ml or less resulted in a negative urine specimen posttreatment for all but one patient who was still positive after treatment with doxycycline. A final MIC of 2.0 ,g/ml in vitro gave mixed posttreatment results. Four patients were negative and four patients were still positive for Tmycoplasma posttreatment. Since 2.0 ug/ml appears to be a borderline concentration, the posttreatment outcome probably depends upon the antibiotic concentration attained during treatment, which is variable from patient to patient. Based on these data, T-mycoplasmas requiring a final MIC of 1.0 ug of the tetracyclines per ml could be considered as "susceptible," a final MIC of 2.0 pg/ml as "intermediate," and a final MIC of 4.0 pg/ml as "resistant." More data are needed to attest to the validity of this classification. DISCUSSION The results of this study indicate that minocycline is an active antibiotic against T-mycoplasmas with a median MIC well below reported blood serum concentrations achievable after therapeutic doses (10, 29) . Doxycycline and demeclocycline, although not as active in vitro as minocycline against the majority of the T-mycoplasmas tested, still gave low median MIC values. Tetracycline was less active than its analogues. Erythromycin required the highest concentrations to inhibit the T strains. Braun et al. (5) , using a different method, showed lower initial and final median MIC values for erythromycin than reported in this study. For tetracycline, however, they found a higher initial and lower final median MIC. Unlike earlier investigations (11, 12, 13, 30) which showed that all T-mycoplasmas were susceptible to the tetracyclines, in this study many T-mycoplasma isolates were found to be resistant to a concentration of 8 ,ug/ml and higher. Recently Ford and Smith (8) Although little is known about attainable levels for these antimicrobial agents in those parts of the human body where these microorganisms are most frequently harbored, good correlation was noticed between T strains highly resistant in vitro and repeated positive cultures posttreatment. It is doubtful that reinfection would be responsible for consistent isolation of T-mycoplasmas for several reasons. Both husband and wife are treated simultaneously with the same antibiotic. Furthermore, this study was done on a patient population with a history of infertility and a strong motivation to initiate a successful pregnancy. And finally, excellent correlation between the in vitro resistant T strains and positive posttreatment cultures was seen in 21 patients.
The results also indicate that the tetracyclines should not be recommended for the empirical treatment of T-mycoplasma infections because of the high frequency of resistant strains. Moreover, the different T-mycoplasmas showed a variability in their susceptibility pattern which cannot be ignored. Some strains may be eradicated with minocycine when treatment with demeclocycline has failed. No one tetracycline analogue can be proposed as the drug of choice because resistance to all four was found. The data obtained in this study illustrated the importance ofsusceptibility testing of T-mycoplasmas as a guide to rational antimicrobial therapy. It is suggested that all patients be recultured at a minimum of 4 weeks after completion of therapy to assure eradication of the T-mycoplasmas.
As mentioned earlier, an inoculum in which the T strains are left in their original environment was preferred because of the complex nutritional requirements of mycoplasmas. Isolation and cloning is in many cases impossible because many cannot be recultured after initial isolation from human clinical sources (15) . The most fastidious T-mycoplasmas often appeared 
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to be the most resistant strains. Furthermore, cell membrane constituents have been known to change depending on the medium in which growth occurred (28) Earlier studies (1, 18, 22, 23) on the viability of mycoplasmas indicate that these organisms survive for relatively long periods when frozen in broth and stored at -20 to -70 C. In our laboratory, it was found that freezing and thawing of the urine sediments had no effect on the titer of the T-mycoplasmas if frozen at -75 F for up to 2 weeks. A change in titer by a factor of 10-1 to 10-2 was noticed for some isolates if stored longer than 2 weeks. The urine sediments used in this study were all tested for susceptibility within a week after freezing, and each specimen was titrated on the day the susceptibility test was performed. All Although this direct in vitro susceptibility method may not be an ideal method, it is a practical method for testing drug susceptibilities of T strains in a relatively short period of time so that the physician can use the information for treatment of T-mycoplasma infections. Cloning of T-mycoplasmas is a lengthy and time-consuming procedure and consequently is not feasible when the clinician is anxious to start therapy. Furthermore, the patients' results attest to the validity of this method. The performance of such in vitro susceptibility determinations uncovered drug-resistant strains and is necessary for the intelligent management of retreatment cases.
In conclusion, tetracyclines are still the drugs of choice for T-mycoplasma infections. They should not, however, be given empirically. A pretreatment susceptibility test and a posttreatment culture are essential. This study also suggests the need for a new drug effective against the tetracycline-resistant, erythromycin-resistant T-mycoplasmas.
